Evidence map›Paper›PMID 31435606›Full record

ArticleInternational journal of reproductive biomedicine2019

The therapeutic potential of amifostine on cyclophosphamide-induced testicular dysfunction in rats: An experimental study.

Coskun Kaya, Ali Barbaros Baseskioglu, Semra Yigitaslan, Fikriye Yasemin Ozatik, Orhan Ozatik, Sema Uslu

Open access · goldAbstract read
In one paragraph

Article in International journal of reproductive biomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Exploring the main effects ofVeterinary research forum : an international quarterly journal · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Coskun KayaDepartment of Urology, Eskisehir City Hospital, Eskisehir, Turkey.
Ali Barbaros BaseskiogluDepartment of Urology, Eskisehir Acibadem Hospital, Eskisehir, Turkey.
Semra YigitaslanDepartment of Pharmacology, Eskisehir Osmangazi University, Eskisehir, Turkey.
Fikriye Yasemin OzatikDepartment of Pharmacology, Kutahya Health Sciences University, Kutahya, Turkey.
Orhan OzatikDepartment of Histology and Embryology, Kutahya Health Sciences University, Kutahya, Turkey.
Sema UsluDepartment of Biochemistry, Eskisehir Osmangazi University, Eskisehir, Turkey.
Eskişehir Osmangazi University · TREskişehir City Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCyclophosphamide (CP) is a well-known alkylating anticancer agent used in the treatment of various malignant and non-malignant tumors. CP may also cause a variety of adverse effects, including reproductive toxicity. Amifostine is known as a cytoprotective drug having antioxidant properties.

objectiveTo evaluate the possible beneficial effects of amifostine on testicular toxicity induced by CP in rats. MATERIALS AND

methodsA total of 35 Sprague-Dawley rats were used in this experimental study. The CP group animals received a single dose of 200 mg/kg CP on Day 8 by intraperitoneal injection and were left untreated for the following seven days. The two remaining groups of animals were treated with 200 mg/kg/day amifostine (AMF 200) and 400 mg/kg/day amifostine (AMF 400) for seven days prior to and following a single intraperitoneal injection of CP. Morphometrical analysis and histological examination of testicular tissue were performed. Serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels were measured in serum using commercial ELISA kits. The epidydimal sperm count was determined.

resultsThe tubular epithelial height in the testis was significantly higher in the AMF400 group compared to other groups (p

conclusionAmifostine, at a dose of 400 mg/kg, may have a protective effect on testicular damage induced by CP in rats.

Indexed as

AmifostineCyclophosphamideRatTestis

Identifiers

PMID31435606
PMCPMC6686653
OpenAlexW2951272742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.